Search for: "BAYER MANUFACTURING" Results 941 - 960 of 982
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Oct 2009, 2:14 am
For that matter, bye-bye those parts of Hatch-Waxman that allow the pervasive patent-related back and forth that occurs between generic and branded drug manufacturers. [read post]
14 Aug 2020, 9:02 am by Abby Meyer
Bayer Healthcare et al., Case No. 5:20-cv-00102 (N.D. [read post]
6 Dec 2010, 2:36 am by Kelly
Buzz Bee Toys Inc (IPBiz) Leviton Manufacturing – ALJ Bullock grants motions to terminate investigation in Ground Fault Circuit Interrupters (337-TA-739) based on settlement (ITC Law Blog) MGM Well Services – Patent case transferred to Southern District of Texas: MGM Well Services, Inc. v. [read post]
19 Sep 2013, 9:53 am by Bexis
., 712 F.3d 51 (1st Cir. 2013), and Harden Manufacturing Corp. v. [read post]
3 Jan 2011, 9:45 pm by Law Lady
GlaxoSmithKline, 18 No. 8 Westlaw Journal Health Law 9, Westlaw Journal Health Law December 21, 2010Pharmaceutical firm GlaxoSmithKline has agreed to pay the government $600 million, and its SB Pharmco subsidiary will plead guilty to violating federal law and pay a $150 million fine for shoddy drug manufacturing at a Puerto Rico plant. [read post]
4 Oct 2021, 10:58 am by Rebecca Tushnet
 My presentation, galloping across a bunch of developments. [read post]
The National Association of Manufacturers has asked the United States Supreme Court to decide whether the Sixth Circuit got the jurisdictional question correct. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
17 Apr 2008, 10:39 am
Bayer AG, 735 N.W.2d 448, 467-68 (Wis. 2007) (drug approvals and possibly other FDA documents); Horne v. [read post]
24 May 2012, 4:23 am by Max Kennerly, Esq.
As Pfizer would have it — and I’m sure Merck and Bayer and every other pharmaceutical company in America would like to have it — drug manufacturers have no duty to investigate and to warn patients about potential side effects, but patients have a legal duty to monitor FDA labeling changes to every drug they’ve ever taken because someday the label might be changed to admit the drug caused a medical condition the patient had in the past or has now. [read post]
20 Oct 2011, 8:22 am by Eric Turkewitz
Even though factual disputes exist between doctors — with a treating physician saying one thing and a hired defense doctor the opposite —  judges are taking cases away from juries and throwing them out on summary judgment, substituting judicially manufactured rules for factual determinations. [read post]
25 Mar 2011, 7:48 am by Stefanie Levine
Patent No. 6,232,328 entitled NON-SYSTEMIC CONTROL OF PARASITES and owned by Bayer Animal Health GmbH. [read post]
17 Feb 2012, 11:29 am by Bexis
Bayer, 922 N.E.2d 309, 319 (Ill. 2009) (rejecting “market theory” of causation; plaintiff “fails to allege that her particular doctor was actually deceived by any of [defendant’s] advertisements or statements”); International Union of Operating Engineers Local No. 68 Welfare Fund v. [read post]
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
13 Sep 2007, 10:48 am
Thus, the Operating Engineers decision that "you can't do this" will inure to the benefit of product manufacturers of all sorts defending against consumer fraud claims - much better than a mere extraterritoriality decision not addressing the merits of the claims would have been.And this holding is ironclad. [read post]
  As we close out the year, we pause to review important developments in agricultural law from 2016. [read post]
27 May 2010, 3:40 pm by Bexis
  Excluding expert opinion based upon “[a]necdotal reports of the claimed adverse experiences” and AERs “filed with manufacturers or regulatory authorities. [read post]